JPWO2023022216A1 - - Google Patents
Info
- Publication number
- JPWO2023022216A1 JPWO2023022216A1 JP2023542451A JP2023542451A JPWO2023022216A1 JP WO2023022216 A1 JPWO2023022216 A1 JP WO2023022216A1 JP 2023542451 A JP2023542451 A JP 2023542451A JP 2023542451 A JP2023542451 A JP 2023542451A JP WO2023022216 A1 JPWO2023022216 A1 JP WO2023022216A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
- C07F9/65616—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021134801 | 2021-08-20 | ||
| PCT/JP2022/031308 WO2023022216A1 (ja) | 2021-08-20 | 2022-08-19 | ウイルス増殖抑制作用を有するヌクレオシド誘導体及びそれらのプロドラッグ |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2023022216A1 true JPWO2023022216A1 (cg-RX-API-DMAC7.html) | 2023-02-23 |
| JPWO2023022216A5 JPWO2023022216A5 (cg-RX-API-DMAC7.html) | 2025-08-18 |
Family
ID=85240607
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023542451A Pending JPWO2023022216A1 (cg-RX-API-DMAC7.html) | 2021-08-20 | 2022-08-19 |
Country Status (13)
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7559223B2 (ja) | 2020-08-24 | 2024-10-01 | ギリアード サイエンシーズ, インコーポレイテッド | リン脂質化合物及びその使用 |
| US11926645B2 (en) | 2020-08-27 | 2024-03-12 | Gilead Sciences, Inc. | Compounds and methods for treatment of viral infections |
| TWI925033B (zh) | 2020-10-16 | 2026-05-11 | 美商基利科學股份有限公司 | 磷脂化合物及其用途 |
| KR20240154647A (ko) | 2022-03-02 | 2024-10-25 | 길리애드 사이언시즈, 인코포레이티드 | 바이러스성 감염 치료를 위한 화합물 및 방법 |
| EP4547665A1 (en) | 2022-06-30 | 2025-05-07 | Gilead Sciences, Inc. | Solid forms of a nucleoside analogue and uses thereof |
| US12357577B1 (en) | 2024-02-02 | 2025-07-15 | Gilead Sciences, Inc. | Pharmaceutical formulations and uses thereof |
| WO2026160341A1 (ja) * | 2025-01-21 | 2026-07-30 | 塩野義製薬株式会社 | ウイルス感染治療用アザ糖誘導体 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2016504284A (ja) * | 2012-11-16 | 2016-02-12 | バイオクリスト ファーマスーティカルズ,インコーポレイテッドBiocryst Pharmaceuticals,Inc. | 抗ウイルス性アザ糖を含有するヌクレオシド |
| JP2019069986A (ja) * | 2012-03-13 | 2019-05-09 | ギリアード サイエンシーズ, インコーポレイテッド | 抗ウイルス処置のための2’−置換カルバヌクレオシド類似体 |
| JP2020534361A (ja) * | 2017-09-18 | 2020-11-26 | ヤンセン・バイオファーマ・インコーポレイテッド | 置換ヌクレオシド、ヌクレオチド、及びそのアナログ |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0071227B1 (en) | 1981-07-31 | 1987-11-11 | Sloan-Kettering Institute For Cancer Research | Anti-leukemic beta-glycosyl c-nucleosides |
| US5985848A (en) | 1997-10-14 | 1999-11-16 | Albert Einstein College Of Medicine Of Yeshiva University | Inhibitors of nucleoside metabolism |
| WO2002018371A1 (en) | 2000-08-29 | 2002-03-07 | Industrial Research Limited | Nucleoside metabolism inhibitors |
| US7098334B2 (en) | 2002-03-25 | 2006-08-29 | Industrial Research Limited | 4-amino-5H-pyrrolo[3,2-d]pyrimidine inhibitors of nucleoside phosphorylases and nucleosidases |
| BR0309581A (pt) | 2002-05-06 | 2005-03-29 | Genelabs Tech Inc | Derivados de nucleosìdeo para tratamento de infecção por vìrus de hepatite c |
| SG182849A1 (en) | 2003-04-25 | 2012-08-30 | Gilead Sciences Inc | Antiviral phosphonate analogs |
| WO2005123087A2 (en) | 2004-06-15 | 2005-12-29 | Merck & Co., Inc. | C-purine nucleoside analogs as inhibitors of rna-dependent rna viral polymerase |
| US7560434B2 (en) | 2004-06-22 | 2009-07-14 | Biocryst Pharmaceuticals, Inc. | AZA nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases |
| AU2005302448B2 (en) | 2004-10-29 | 2012-07-19 | Biocryst Pharmaceuticals, Inc. | Therapeutic furopyrimidines and thienopyrimidines |
| WO2007069924A1 (en) | 2005-12-15 | 2007-06-21 | Industrial Research Limited | Deazapurine analogs of 4'-aza-l-nucleosides |
| NZ598927A (en) | 2007-01-12 | 2013-09-27 | Biocryst Pharm Inc | Antiviral nucleoside analogs |
| DK2155758T3 (da) | 2007-05-10 | 2012-11-05 | Biocryst Pharm Inc | Tetrahydrofuro[3,4-d]dioxolanforbindelser til anvendelse i behandlingen af virusinfektioner og cancer |
| EP2313102A2 (en) | 2008-07-03 | 2011-04-27 | Biota Scientific Management | Bycyclic nucleosides and nucleotides as therapeutic agents |
| TW201305185A (zh) | 2010-09-13 | 2013-02-01 | 吉李德科學股份有限公司 | 用於抗病毒治療之2’-氟取代之碳-核苷類似物 |
| US9290501B2 (en) | 2010-11-29 | 2016-03-22 | Albert Einstein College Of Medicine, Inc. | Methods, assays and compounds for treating bacterial infections by inhibiting methylthioinosine phosphorylase |
| AR090699A1 (es) | 2012-04-18 | 2014-12-03 | Biocryst Pharm Inc | Compuestos inhibidores de la actividad de la arn polimerasa viral |
| WO2014035140A2 (en) | 2012-08-30 | 2014-03-06 | Kainos Medicine, Inc. | Compounds and compositions for modulating histone methyltransferase activity |
| WO2014093924A1 (en) | 2012-12-13 | 2014-06-19 | Moderna Therapeutics, Inc. | Modified nucleic acid molecules and uses thereof |
| AU2014265483B2 (en) | 2013-05-14 | 2018-08-02 | Biocryst Pharmaceuticals, Inc. | Anti-influenza compositions and methods |
| UA119050C2 (uk) | 2013-11-11 | 2019-04-25 | Ґілеад Саєнсиз, Інк. | ПІРОЛО[1.2-f][1.2.4]ТРИАЗИНИ, ЯКІ ВИКОРИСТОВУЮТЬСЯ ДЛЯ ЛІКУВАННЯ РЕСПІРАТОРНО-СИНЦИТІАЛЬНИХ ВІРУСНИХ ІНФЕКЦІЙ |
| WO2015143712A1 (en) | 2014-03-28 | 2015-10-01 | Merck Sharp & Dohme Corp. | 4'-substituted nucleoside reverse transcriptase inhibitors |
| TWI698444B (zh) | 2014-10-29 | 2020-07-11 | 美商基利科學股份有限公司 | 製備核糖苷的方法 |
| CA2966033A1 (en) | 2014-10-31 | 2016-05-06 | Cocrystal Pharma, Inc. | 2',2'-dihalo nucleoside analogs for treatment of the flaviviridae family of viruses and cancer |
| JPWO2018199048A1 (ja) | 2017-04-25 | 2020-05-07 | 大原薬品工業株式会社 | ヌクレオシド系抗がん剤または抗ウィルス剤の5’位モノ燐酸ジベンジルエステル誘導体 |
| WO2018230479A1 (ja) | 2017-06-13 | 2018-12-20 | 大原薬品工業株式会社 | ヌクレオシド系抗がん剤又は抗ウィルス剤の5'位シリルエーテル誘導体 |
| EP3737359A4 (en) | 2018-01-12 | 2021-11-03 | Board of Regents of the University of Nebraska | ANTIVIRAL PRODRUGS AND THEIR FORMULATIONS |
| WO2021040356A1 (en) | 2019-08-23 | 2021-03-04 | Kainos Medicine, Inc. | C-nucleosides, c-nucleotides and their analogs, equivalents and prodrugs thereof for ectonucleotidase inhibition |
| CN112778310B (zh) | 2020-04-20 | 2025-05-30 | 中国科学院上海药物研究所 | 核苷类似物或含有核苷类似物的组合制剂在抗病毒中的应用 |
| CN112062800B (zh) | 2020-09-02 | 2022-11-18 | 广东东阳光药业有限公司 | 核苷化合物的氨基磷酸酯衍生物及其用途 |
| CN112010916B (zh) | 2020-09-09 | 2022-12-27 | 广东东阳光药业有限公司 | 核苷化合物的氨基磷酸酯衍生物及其用途 |
-
2022
- 2022-08-19 IL IL310854A patent/IL310854A/en unknown
- 2022-08-19 US US18/684,486 patent/US20250170155A1/en active Pending
- 2022-08-19 CA CA3229752A patent/CA3229752A1/en active Pending
- 2022-08-19 JP JP2023542451A patent/JPWO2023022216A1/ja active Pending
- 2022-08-19 MX MX2024002116A patent/MX2024002116A/es unknown
- 2022-08-19 WO PCT/JP2022/031308 patent/WO2023022216A1/ja not_active Ceased
- 2022-08-19 PE PE2024000272A patent/PE20240654A1/es unknown
- 2022-08-19 CN CN202280069993.0A patent/CN118119624A/zh active Pending
- 2022-08-19 EP EP22858533.7A patent/EP4389750A4/en active Pending
- 2022-08-19 KR KR1020247008024A patent/KR20240050362A/ko active Pending
- 2022-08-19 AU AU2022331233A patent/AU2022331233A1/en active Pending
-
2024
- 2024-02-09 ZA ZA2024/01270A patent/ZA202401270B/en unknown
- 2024-03-13 CO CONC2024/0003018A patent/CO2024003018A2/es unknown
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2019069986A (ja) * | 2012-03-13 | 2019-05-09 | ギリアード サイエンシーズ, インコーポレイテッド | 抗ウイルス処置のための2’−置換カルバヌクレオシド類似体 |
| JP2016504284A (ja) * | 2012-11-16 | 2016-02-12 | バイオクリスト ファーマスーティカルズ,インコーポレイテッドBiocryst Pharmaceuticals,Inc. | 抗ウイルス性アザ糖を含有するヌクレオシド |
| JP2020534361A (ja) * | 2017-09-18 | 2020-11-26 | ヤンセン・バイオファーマ・インコーポレイテッド | 置換ヌクレオシド、ヌクレオチド、及びそのアナログ |
Also Published As
| Publication number | Publication date |
|---|---|
| ZA202401270B (en) | 2026-05-27 |
| MX2024002116A (es) | 2024-03-06 |
| EP4389750A1 (en) | 2024-06-26 |
| CO2024003018A2 (es) | 2024-03-18 |
| PE20240654A1 (es) | 2024-04-04 |
| AU2022331233A1 (en) | 2024-02-29 |
| CA3229752A1 (en) | 2023-02-23 |
| KR20240050362A (ko) | 2024-04-18 |
| IL310854A (en) | 2024-04-01 |
| WO2023022216A1 (ja) | 2023-02-23 |
| US20250170155A1 (en) | 2025-05-29 |
| EP4389750A4 (en) | 2025-10-01 |
| CN118119624A (zh) | 2024-05-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112023012656A2 (cg-RX-API-DMAC7.html) | ||
| BR102020021170B1 (pt) | Composição, formulações orais e uso | |
| BR102020004560B1 (pt) | Rotor eólico utilizando duplas-pás inteiriças para geração de potência | |
| CN305937031S (zh) | 酒桶(自烤酒) | |
| CN305923515S (zh) | Usb投影灯(l-1) | |
| CN305940999S (zh) | 吊灯(8508) | |
| CN305932941S (zh) | 摆件(仙桃筶杯) | |
| CN305929630S (zh) | 端头连接件 | |
| CN305907180S (zh) | 手电筒(x73) | |
| CN305904739S (zh) | 数据中心一体化机柜(003) | |
| CN305935948S (zh) | 转角柜 | |
| CN305925933S (zh) | 水壶(棱形) | |
| CN305856819S (zh) | 桌子(sl-1塑料学习桌) | |
| CN305905649S (zh) | 书籍封面 | |
| CN305909271S (zh) | 圆餐桌(hz9930) | |
| CN305925289S (zh) | 休闲几(hx9930) | |
| CN305914225S (zh) | 灭蚊器(dh-mw10) | |
| CN305860998S (zh) | 实训台(工业机器人上下料通用) | |
| CN305927522S (zh) | 花盆(xw-1818) | |
| CN305911994S (zh) | 车把(q5) | |
| CN305857215S (zh) | 茶杯套件 | |
| CN305852244S (zh) | 地板清洁机夹具 | |
| CN305908823S (zh) | 纺织面料(jtm166-1) | |
| CN305922170S (zh) | 压力桶(内置式) | |
| CN305907801S (zh) | 彩妆盘(鹤禧觉色·岁朝清供一) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20250804 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20250804 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20260526 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20260724 |